IBDEI07V ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10331,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,10332,0)
 ;;=362.05^^72^691^62
 ;;^UTILITY(U,$J,358.3,10332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10332,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,10332,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,10332,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,10333,0)
 ;;=362.06^^72^691^98
 ;;^UTILITY(U,$J,358.3,10333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10333,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,10333,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,10333,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,10334,0)
 ;;=379.27^^72^691^103
 ;;^UTILITY(U,$J,358.3,10334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10334,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,10334,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,10334,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,10335,0)
 ;;=115.02^^72^691^44
 ;;^UTILITY(U,$J,358.3,10335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10335,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,10335,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,10335,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,10336,0)
 ;;=190.5^^72^691^58
 ;;^UTILITY(U,$J,358.3,10336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10336,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,10336,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,10336,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,10337,0)
 ;;=198.4^^72^691^59
 ;;^UTILITY(U,$J,358.3,10337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10337,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,10337,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,10337,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,10338,0)
 ;;=200.00^^72^691^81
 ;;^UTILITY(U,$J,358.3,10338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10338,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,10338,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,10338,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,10339,0)
 ;;=228.03^^72^691^38
 ;;^UTILITY(U,$J,358.3,10339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10339,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,10339,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,10339,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,10340,0)
 ;;=228.09^^72^691^39
 ;;^UTILITY(U,$J,358.3,10340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10340,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,10340,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,10340,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,10341,0)
 ;;=360.00^^72^691^73
 ;;^UTILITY(U,$J,358.3,10341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10341,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
 ;;^UTILITY(U,$J,358.3,10341,1,4,0)
 ;;=4^360.00
 ;;^UTILITY(U,$J,358.3,10341,2)
 ;;=^40605
 ;;^UTILITY(U,$J,358.3,10342,0)
 ;;=360.03^^72^691^21
 ;;^UTILITY(U,$J,358.3,10342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10342,1,3,0)
 ;;=3^Chronic Endophthalmitis
 ;;^UTILITY(U,$J,358.3,10342,1,4,0)
 ;;=4^360.03
 ;;^UTILITY(U,$J,358.3,10342,2)
 ;;=^268547
 ;;^UTILITY(U,$J,358.3,10343,0)
 ;;=361.02^^72^691^76
 ;;^UTILITY(U,$J,358.3,10343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10343,1,3,0)
 ;;=3^Recent RD w/ Multiple Defects
 ;;^UTILITY(U,$J,358.3,10343,1,4,0)
 ;;=4^361.02
 ;;^UTILITY(U,$J,358.3,10343,2)
 ;;=^268587
 ;;^UTILITY(U,$J,358.3,10344,0)
 ;;=361.03^^72^691^75
 ;;^UTILITY(U,$J,358.3,10344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10344,1,3,0)
 ;;=3^Recent RD w/ Giant Tear
 ;;^UTILITY(U,$J,358.3,10344,1,4,0)
 ;;=4^361.03
 ;;^UTILITY(U,$J,358.3,10344,2)
 ;;=^268588
 ;;^UTILITY(U,$J,358.3,10345,0)
 ;;=361.04^^72^691^79
 ;;^UTILITY(U,$J,358.3,10345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10345,1,3,0)
 ;;=3^Ret Det,Partial w/ Dialysis
 ;;^UTILITY(U,$J,358.3,10345,1,4,0)
 ;;=4^361.04
 ;;^UTILITY(U,$J,358.3,10345,2)
 ;;=^268589
 ;;^UTILITY(U,$J,358.3,10346,0)
 ;;=361.12^^72^691^8
 ;;^UTILITY(U,$J,358.3,10346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10346,1,3,0)
 ;;=3^Bullous Retinoschisis
 ;;^UTILITY(U,$J,358.3,10346,1,4,0)
 ;;=4^361.12
 ;;^UTILITY(U,$J,358.3,10346,2)
 ;;=^268596
 ;;^UTILITY(U,$J,358.3,10347,0)
 ;;=361.2^^72^691^102
 ;;^UTILITY(U,$J,358.3,10347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10347,1,3,0)
 ;;=3^Uveal Effusion/SRD
 ;;^UTILITY(U,$J,358.3,10347,1,4,0)
 ;;=4^361.2
 ;;^UTILITY(U,$J,358.3,10347,2)
 ;;=^268601
 ;;^UTILITY(U,$J,358.3,10348,0)
 ;;=361.9^^72^691^83
 ;;^UTILITY(U,$J,358.3,10348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10348,1,3,0)
 ;;=3^Retinal Detachment NOS
 ;;^UTILITY(U,$J,358.3,10348,1,4,0)
 ;;=4^361.9
 ;;^UTILITY(U,$J,358.3,10348,2)
 ;;=^105529
 ;;^UTILITY(U,$J,358.3,10349,0)
 ;;=362.10^^72^691^95
 ;;^UTILITY(U,$J,358.3,10349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10349,1,3,0)
 ;;=3^Rubella Retinopathy
 ;;^UTILITY(U,$J,358.3,10349,1,4,0)
 ;;=4^362.10
 ;;^UTILITY(U,$J,358.3,10349,2)
 ;;=^12267
 ;;^UTILITY(U,$J,358.3,10350,0)
 ;;=362.12^^72^691^22
 ;;^UTILITY(U,$J,358.3,10350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10350,1,3,0)
 ;;=3^Coats' Disease
 ;;^UTILITY(U,$J,358.3,10350,1,4,0)
 ;;=4^362.12
 ;;^UTILITY(U,$J,358.3,10350,2)
 ;;=^268612
 ;;^UTILITY(U,$J,358.3,10351,0)
 ;;=362.13^^72^691^88
 ;;^UTILITY(U,$J,358.3,10351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10351,1,3,0)
 ;;=3^Retinal Vascular Changes
 ;;^UTILITY(U,$J,358.3,10351,1,4,0)
 ;;=4^362.13
 ;;^UTILITY(U,$J,358.3,10351,2)
 ;;=^268614
 ;;^UTILITY(U,$J,358.3,10352,0)
 ;;=362.14^^72^691^82
 ;;^UTILITY(U,$J,358.3,10352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10352,1,3,0)
 ;;=3^Retina Microaneurysm NOS
 ;;^UTILITY(U,$J,358.3,10352,1,4,0)
 ;;=4^362.14
 ;;^UTILITY(U,$J,358.3,10352,2)
 ;;=^268615
 ;;^UTILITY(U,$J,358.3,10353,0)
 ;;=362.17^^72^691^52
 ;;^UTILITY(U,$J,358.3,10353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10353,1,3,0)
 ;;=3^Macroaneurysm
 ;;^UTILITY(U,$J,358.3,10353,1,4,0)
 ;;=4^362.17
 ;;^UTILITY(U,$J,358.3,10353,2)
 ;;=^268617
 ;;^UTILITY(U,$J,358.3,10354,0)
 ;;=362.21^^72^691^71
 ;;^UTILITY(U,$J,358.3,10354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10354,1,3,0)
 ;;=3^Prematurity-ROP
 ;;^UTILITY(U,$J,358.3,10354,1,4,0)
 ;;=4^362.21
 ;;^UTILITY(U,$J,358.3,10354,2)
 ;;=^105733
 ;;^UTILITY(U,$J,358.3,10355,0)
 ;;=362.29^^72^691^63
 ;;^UTILITY(U,$J,358.3,10355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10355,1,3,0)
 ;;=3^Nondiabetic PR
 ;;^UTILITY(U,$J,358.3,10355,1,4,0)
 ;;=4^362.29
 ;;^UTILITY(U,$J,358.3,10355,2)
 ;;=^268619
 ;;^UTILITY(U,$J,358.3,10356,0)
 ;;=362.30^^72^691^40
 ;;^UTILITY(U,$J,358.3,10356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10356,1,3,0)
 ;;=3^Hemiretinal Vein Occlusion
 ;;^UTILITY(U,$J,358.3,10356,1,4,0)
 ;;=4^362.30
 ;;^UTILITY(U,$J,358.3,10356,2)
 ;;=^105640
 ;;^UTILITY(U,$J,358.3,10357,0)
 ;;=362.37^^72^691^9
 ;;^UTILITY(U,$J,358.3,10357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10357,1,3,0)
 ;;=3^CRVO-Partial
 ;;^UTILITY(U,$J,358.3,10357,1,4,0)
 ;;=4^362.37
 ;;^UTILITY(U,$J,358.3,10357,2)
 ;;=^268627
 ;;^UTILITY(U,$J,358.3,10358,0)
 ;;=362.50^^72^691^51
 ;;^UTILITY(U,$J,358.3,10358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10358,1,3,0)
 ;;=3^Mac Degen,Senile/Atrophy
 ;;^UTILITY(U,$J,358.3,10358,1,4,0)
 ;;=4^362.50
 ;;^UTILITY(U,$J,358.3,10358,2)
 ;;=^73072
 ;;^UTILITY(U,$J,358.3,10359,0)
 ;;=362.70^^72^691^28
 ;;^UTILITY(U,$J,358.3,10359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10359,1,3,0)
 ;;=3^Degen/Hered Disorder
 ;;^UTILITY(U,$J,358.3,10359,1,4,0)
 ;;=4^362.70
 ;;^UTILITY(U,$J,358.3,10359,2)
 ;;=^268650
 ;;^UTILITY(U,$J,358.3,10360,0)
 ;;=362.74^^72^691^91
 ;;^UTILITY(U,$J,358.3,10360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10360,1,3,0)
 ;;=3^Retinitis Pigmentosa
 ;;^UTILITY(U,$J,358.3,10360,1,4,0)
 ;;=4^362.74
 ;;^UTILITY(U,$J,358.3,10360,2)
 ;;=^105693
 ;;^UTILITY(U,$J,358.3,10361,0)
 ;;=362.75^^72^691^50
 ;;^UTILITY(U,$J,358.3,10361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10361,1,3,0)
 ;;=3^Mac Degen,Juvenile
 ;;^UTILITY(U,$J,358.3,10361,1,4,0)
 ;;=4^362.75
 ;;^UTILITY(U,$J,358.3,10361,2)
 ;;=^268656
 ;;^UTILITY(U,$J,358.3,10362,0)
 ;;=362.76^^72^691^74
 ;;^UTILITY(U,$J,358.3,10362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10362,1,3,0)
 ;;=3^RPE Hypertrophy
 ;;^UTILITY(U,$J,358.3,10362,1,4,0)
 ;;=4^362.76
 ;;^UTILITY(U,$J,358.3,10362,2)
 ;;=^268657
 ;;^UTILITY(U,$J,358.3,10363,0)
 ;;=362.82^^72^691^85
 ;;^UTILITY(U,$J,358.3,10363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10363,1,3,0)
 ;;=3^Retinal Exudates
 ;;^UTILITY(U,$J,358.3,10363,1,4,0)
 ;;=4^362.82
 ;;^UTILITY(U,$J,358.3,10363,2)
 ;;=^268659
 ;;^UTILITY(U,$J,358.3,10364,0)
 ;;=363.12^^72^691^68
 ;;^UTILITY(U,$J,358.3,10364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10364,1,3,0)
 ;;=3^Periph Disem Choroiditis
 ;;^UTILITY(U,$J,358.3,10364,1,4,0)
 ;;=4^363.12
 ;;^UTILITY(U,$J,358.3,10364,2)
 ;;=^268675
 ;;^UTILITY(U,$J,358.3,10365,0)
 ;;=363.15^^72^691^1
 ;;^UTILITY(U,$J,358.3,10365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10365,1,3,0)
 ;;=3^AMPPE
 ;;^UTILITY(U,$J,358.3,10365,1,4,0)
 ;;=4^363.15
 ;;^UTILITY(U,$J,358.3,10365,2)
 ;;=^268678
 ;;^UTILITY(U,$J,358.3,10366,0)
 ;;=363.33^^72^691^96
 ;;^UTILITY(U,$J,358.3,10366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10366,1,3,0)
 ;;=3^Scars of Post Pole of Chorioret
 ;;^UTILITY(U,$J,358.3,10366,1,4,0)
 ;;=4^363.33
 ;;^UTILITY(U,$J,358.3,10366,2)
 ;;=^268681
 ;;^UTILITY(U,$J,358.3,10367,0)
 ;;=363.41^^72^691^97
 ;;^UTILITY(U,$J,358.3,10367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10367,1,3,0)
 ;;=3^Senile Atrophy of Choroid
 ;;^UTILITY(U,$J,358.3,10367,1,4,0)
 ;;=4^363.41
 ;;^UTILITY(U,$J,358.3,10367,2)
 ;;=^268686
 ;;^UTILITY(U,$J,358.3,10368,0)
 ;;=363.43^^72^691^4
 ;;^UTILITY(U,$J,358.3,10368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10368,1,3,0)
 ;;=3^Angioid Streaks
 ;;^UTILITY(U,$J,358.3,10368,1,4,0)
 ;;=4^363.43
 ;;^UTILITY(U,$J,358.3,10368,2)
 ;;=^7492
 ;;^UTILITY(U,$J,358.3,10369,0)
 ;;=363.50^^72^691^42
 ;;^UTILITY(U,$J,358.3,10369,1,0)
 ;;=^358.31IA^4^2
